RxDoctor Payments Data

Jared Barber, MD

Family Medicine · Blountstown, FLNPI 1104486588

Payments from drug & device makers

$1,317in general payments, 2019–2025

Across 73 payments — averaging $18.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$269
  • Pfizer$184
  • Lilly USA, LLC$121
  • Novartis$113
  • AbbVie$106
  • Novo Nordisk$96
  • plus $428 from 13 others

What the payments were for

  • Food & beverage$1,317100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,317 in reported general payments places this provider in the 65th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$4,630
Medicare patients
30
Services billed
65

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide90$111,364
EliquisApixaban141$93,757
JanuviaSitagliptin Phosphate79$47,670
Trelegy ElliptaFluticasone/Umeclidin/Vilanter49$38,586
JardianceEmpagliflozin49$35,292
FarxigaDapagliflozin Propanediol40$29,925
TrulicityDulaglutide16$29,119
OzempicSemaglutide21$24,071
EntrestoSacubitril/Valsartan28$21,204
Janumet XrSitagliptin Phos/Metformin Hcl27$14,782
Breztri AerosphereBudesonide/Glycopyr/Formoterol23$14,422
XareltoRivaroxaban18$13,686
MyrbetriqMirabegron27$12,028
Lantus SolostarInsulin Glargine,hum.Rec.Anlog52$6,946
Repatha SureclickEvolocumab12$6,064

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$121$140,484106 claims
PfizerEliquis$184$93,757141 claims
MerckJanuvia, Janumet Xr$42$62,453106 claims
AstraZenecaFarxiga, Breztri Aerosphere$269$44,34763 claims
GSKTrelegy Ellipta$30$38,58649 claims
Boehringer IngelheimJardiance$14$35,29249 claims
Novo NordiskOzempic$96$24,07121 claims
NovartisEntresto$113$21,20428 claims
AbbVieSynthroid$106$2,06837 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Blountstown

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →